NCT05642195 2026-04-22Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung CancerNational Institutes of Health Clinical Center (CC)Phase 1/2 Suspended30 enrolled
NCT07227415 2026-04-20Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell CancerPfizerPhase 1/2 Recruiting224 enrolled
NCT05559879 2026-04-15Cabozantinib and Dostarlimab in Recurrent Gynecologic CarcinosarcomaUniversity of Alabama at BirminghamPhase 1/2 Recruiting37 enrolled
NCT05232851 2026-04-14A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx CancerMayo ClinicPhase 1/2 Active not recruiting20 enrolled 11 charts
NCT03093116 2026-04-03TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 4 FDA
NCT04261855 2026-03-27GoTHAMMelanoma and Skin Cancer Trials LimitedPhase 1/2 Active not recruiting19 enrolled